Dekui Zhang

机构：Lanzhou University Second Hospital, Lanzhou University · ORCID：0000-0002-4883-8713

发表论文 62 篇 · 总被引 763 次 · h-index 15

代表论文

• Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China (2023 · Helicobacter · 被引 55)
• The role of hepatic microenvironment in hepatic fibrosis development (2022 · Annals of Medicine · 被引 31)
• Dihydromyricetin alleviates inflammatory bowel disease associated intestinal fibrosis by inducing autophagy through the PI3K/AKT/mTOR signaling pathway (2023 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 16)
• Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease (2022 · European Journal of Pharmacology · 被引 16)
• Colloidal bismuth pectin‐containing quadruple therapy as the first‐line treatment of Helicobacter pylori infection: A multicenter, randomized, double‐blind, non‐inferiority clinical trial (2023 · Helicobacter · 被引 10)
• Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies (2025 · Frontiers in Immunology · 被引 9)